=>Hypersensibilité au tocilizumab =>Hypersensibilité aux protéines de hamster =>Infection sévère =>Infection non contrôlée =>Absence de contraception féminine efficace =>Allaitement =>ALAT > 5 LSN =>ASAT > 5 LSN =>Grossesse =>Neutropénie < 2000/mm3 =>Thrombopénie < 50000/mm3 . . .
=>Tocilizumab - Adulte jeune - Fertilité
=>Tocilizumab - Allaitement
=>Tocilizumab - Enfant
=>Tocilizumab - Grossesse
=>Tocilizumab - Personne âgée
=>Tocilizumab Affection cardiaque Coeur
=>Tocilizumab - Affection respiratoire Poumons
=>Tocilizumab - Foie
=>Tocilizumab - Reins
=>Tocilizumab - Indications
=>Tocilizumab - Contre-Indications
=>Tocilizumab - Effets indésirables
=>Tocilizumab - Formes et Spécialités
=>Tocilizumab - Mécanisme d'action
=>Tocilizumab - Posologie
=>Tocilizumab - Précautions d'emploi
=>Tocilizumab - Surdosage - Pharmacocinétique
=>tocilizumab : Impact sur les examens biologiques
=>tocilizumab : Interactions médicamenteuses
